IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Affinity Asset Advisors, LLC

Portfolio Profile

CIK: 0001773195 | NEW YORK, NY

Investment Profile

Style

Deep Value

Turnover

High

Orientation

Concentrated trader
$2.0B
AUM
104
Positions
42.64%
Top 10 Conc.
68.71%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Roivant Sciences LTD(ROIV)3,750,000$132.7M6.00%
2Apogee Therapeutics Inc(APGE)987,000$131.0M5.92%
3Spyre Therapeutics Inc(SYRE)1,279,134$113.6M5.13%
4Xenon Pharmaceuticals Inc(XENE)1,595,000$96.3M4.35%
5Erasca Inc(ERAS)5,250,000$96.2M4.35%
6

Sector Allocation

Latest filing, equity positions only

Healthcare83.6% · $1.7B
Unclassified16.4% · $335.3M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare88.5%83.6%-4.9%
Unclassified11.5%16.4%+4.9%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$355.5M | 81 pos.
$547.5M | 82 pos.
$807.8M | 95 pos.
$867.5M | 98 pos.
$732.8M | 86 pos.
$746.0M | 85 pos.
Insmed Inc(INSM)
650,000
$69.3M
3.13%
7Praxis Precision Medicines I(PRAX)185,000$61.9M2.80%
8Alkermes PLC(ALKS)1,125,000$58.9M2.66%
9Oruka Therapeutics Inc(ORKA)590,000$56.2M2.54%
10Anaptysbio Inc(ANAB)826,109$55.8M2.52%
Cap SizePrev %Curr %Change
Mid Cap49.75%42.15%-7.6%
Small Cap22.15%25.31%+3.16%
Unclassified11.5%16.4%+4.9%
Micro Cap5.34%8.4%+3.06%
Large Cap11.26%7.74%-3.52%
$1.0B | 98 pos.
$732.2M | 91 pos.
$1.1B | 96 pos.
$1.8B | 95 pos.
$1.9B | 105 pos.
$2.2B | 113 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

25
New
17
Closed
33
Increased
31
Decreased
24
Unchanged